181 related articles for article (PubMed ID: 21399988)
1. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of morin and its new oxovanadium(IV) complex as antioxidant and specific anti-cancer agents.
Naso LG; Lezama L; Rojo T; Etcheverry SB; Valcarcel M; Roura M; Salado C; Ferrer EG; Williams PA
Chem Biol Interact; 2013 Nov; 206(2):289-301. PubMed ID: 24125835
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture.
León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2012 Jun; 147(1-3):403-7. PubMed ID: 22246791
[TBL] [Abstract][Full Text] [Related]
6. Role of oxidative stress in the antitumoral action of a new vanadyl(IV) complex with the flavonoid chrysin in two osteoblast cell lines: relationship with the radical scavenger activity.
Naso L; Ferrer EG; Lezama L; Rojo T; Etcheverry SB; Williams P
J Biol Inorg Chem; 2010 Aug; 15(6):889-902. PubMed ID: 20364393
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and biological activity of oxovanadium (IV) complexes with cyclic polyalcohols.
Etcheverry SB; Barrio DA; Zinczuk J; Williams PA; Baran EJ
J Inorg Biochem; 2005 Dec; 99(12):2322-7. PubMed ID: 16219358
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, antitumoral and osteogenic activities of quercetin vanadyl(IV) complexes.
Ferrer EG; Salinas MV; Correa MJ; Naso L; Barrio DA; Etcheverry SB; Lezama L; Rojo T; Williams PA
J Biol Inorg Chem; 2006 Sep; 11(6):791-801. PubMed ID: 16821038
[TBL] [Abstract][Full Text] [Related]
9. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of a vanadyl(IV) complex with a multidentate oxygen donor in osteoblast cell lines in culture.
Rivadeneira J; Di Virgilio AL; Barrio DA; Muglia CI; Bruzzone L; Etcheverry SB
Med Chem; 2010 Jan; 6(1):9-23. PubMed ID: 20402656
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure and in vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2'-methylbenzoyl) hydrazone bridged copper(II) coordination polymer.
Senthil Raja D; Ramachandran E; Bhuvanesh NS; Natarajan K
Eur J Med Chem; 2013 Jun; 64():148-59. PubMed ID: 23644198
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, immunomodulation and cytotoxic effects of vanadium (IV) complexes.
Ashiq U; Jamal RA; Mesaik MA; Mahroof-Tahir M; Shahid S; Khan KM
Med Chem; 2014 May; 10(3):287-99. PubMed ID: 23876231
[TBL] [Abstract][Full Text] [Related]
13. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
14. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage.
Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC
Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452
[TBL] [Abstract][Full Text] [Related]
15. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
Dong Y; Narla RK; Sudbeck E; Uckun FM
J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant effects of the VO(IV) hesperidin complex and its role in cancer chemoprevention.
Etcheverry SB; Ferrer EG; Naso L; Rivadeneira J; Salinas V; Williams PA
J Biol Inorg Chem; 2008 Mar; 13(3):435-47. PubMed ID: 18097692
[TBL] [Abstract][Full Text] [Related]
18. [Anticancer activity of oxovanadium compounds].
Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
[TBL] [Abstract][Full Text] [Related]
19. Photocytotoxicity and DNA cleavage activity of L-arg and L-lys Schiff base oxovanadium(IV) complexes having phenanthroline bases.
Sasmal PK; Majumdar R; Dighe RR; Chakravarty AR
Dalton Trans; 2010 Aug; 39(30):7104-13. PubMed ID: 20563340
[TBL] [Abstract][Full Text] [Related]
20. Water-soluble DNA minor groove binders as potential chemotherapeutic agents: synthesis, characterization, DNA binding and cleavage, antioxidation, cytotoxicity and HSA interactions.
Fu XB; Liu DD; Lin Y; Hu W; Mao ZW; Le XY
Dalton Trans; 2014 Jun; 43(23):8721-37. PubMed ID: 24770345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
